Molecular modeling and preclinical evaluation of radioiodinated tenoxicam for inflammatory disease diagnosis
Sakr T.M.; Ibrahim I.T.; Abd-Alla W.H.
Date issued:
2018
Publisher:
Springer Netherlands
Series Info:
Journal of Radioanalytical and Nuclear Chemistry
316
Type:
Article
Keywords:
October University for Modern Sciences and Arts
,
جامعة أكتوبر للعلوم الحديثة والآداب
,
University of Modern Sciences and Arts
,
MSA University
,
Cyclooxygensase enzyme
,
Imaging
,
Inflammation
,
Molecular docking
,
Radioiodination
,
Tenoxicam
,
celecoxib
,
ibuprofen
,
iodine 125
,
tenoxicam
,
tosylchloramide sodium
,
animal experiment
,
animal model
,
animal tissue
,
Article
,
bacterial infection
,
binding affinity
,
binding site
,
concentration (parameters)
,
controlled study
,
drug distribution
,
drug stability
,
drug structure
,
hydrogen bond
,
in vitro study
,
inflammatory disease
,
molecular docking
,
molecular interaction
,
molecular model
,
mouse
,
mouse model
,
nonhuman
,
pH measurement
,
preclinical study
,
radioactivity
,
radiochemistry
,
radioiodination
,
reaction time
Abstract:
Abstract: The aim of the presented study is to investigate a new promising radiopharmaceutical tracer able to visualize and differentiate inflammation versus infection in early stages. Radioiodinated tenoxicam (125I-tenoxicam) was prepared and its radiochemical yield and in vitro stability were assayed. The biodistribution studies were conducted on two different mice models: sterile inflammation and bacterial infection mice models. 125I-tenoxicam showed high T/NT accumulation in the inflammatory tissues revealing high selectivity to the inflammatory tissues in contrast to infection bearing mice. The docking study using CDOCKER protocol for tenoxicam and radioiodinated tenoxicam with COX enzymes was performed to confirm that radioiodinated tenoxicam still retaining COX enzymes selectivity. � 2018, Akad�miai Kiad�, Budapest, Hungary.
Description:
Scopus
MSA Google Scholar
Show full item record